100mg tablets are restricted to neurology use only.
RNOH:
No restriction stated
UCLH:
WH:
100mg tablets are restricted to neurology use/advice only.
Prednisolone
Formulary
Provider notes
NMUH:
Enteric Coated preparations are Non-Formulary
RFL:
No restriction stated
RNOH:
Prednisolone enteric-coated and soluble tablets are non-formulary. Please contact Pharmacy if a patient requiring prednisolone tablets has a swallowing difficulty
UCLH:
WH:
Soluble tablets and liquid preparations restricted to Paediatrics
Triamcinolone
(Kenalog®)
(Endocrinology)
Formulary
Provider notes
NMUH:
No restriction stated
RFL:
No restriction stated
RNOH:
No restriction stated
UCLH:
WH:
Non-formulary
06.03.02
Disadvantages of corticosteroids
06.03.02
Use of corticosteroids
06.03.02
Pregnancy and breastfeeding
06.03.02
Administration
06.03.02
Withdrawal of corticosteroids
....
Non Formulary Items
Cortisone Acetate (Cortisone)
Non Formulary
Hydrocortisone acetate
(Hydrocortisab®)
Non Formulary
Hydrocortisone modified release
(Plenadren®)
Non Formulary
Not approved for adrenal insufficiency (September 2014)
Prednisone modified release
(Lodotra®)
Non Formulary
Key
Notes
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Restricted Drug
Unlicensed
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Homecare
Traffic Light Status Information
Status
Description
Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.
Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.
Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.
Medicines which should normally be prescribed by specialists only (hospital only).
For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.
Medicines not recommended for routine use in primary or secondary care.
Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.
Restricted
